Memphis, TN September 28th, 2018 – Cognate BioServices, a leading contract development and manufacturing organization (“CDMO”) in the global cellular therapies industry, today announced a letter of intent for a collaboration agreement with Terumo BCT, a leading technology provider in the cell therapy market. Under the terms […]
Read more →Cognate BioServices and FloDesign Sonics Announce Collaboration to Advance Acoustic Cell Processing as a Platform for Cell Therapy Manufacturing Wilbraham, MA, September 4, 2018 – FloDesign Sonics, a global leader in acoustic cell processing for cell and gene therapies, and Cognate BioServices, a leading contract development and […]
Read more →Cognate Completes Management Buyout and Raises Growth Capital to Fund Commercial Cellular Therapy Manufacturing Expansion BALTIMORE, MD and MEMPHIS, TN – Cognate BioServices, a leading contract development and manufacturing organization (“CDMO”) in the global cellular therapies industry, announced today it has completed a management buyout (“MBO”) […]
Read more →